Does TIRZEPATIDE Cause Product communication issue? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Product communication issue have been filed in association with TIRZEPATIDE (Zepbound). This represents 0.0% of all adverse event reports for TIRZEPATIDE.
9
Reports of Product communication issue with TIRZEPATIDE
0.0%
of all TIRZEPATIDE reports
0
Deaths
2
Hospitalizations
How Dangerous Is Product communication issue From TIRZEPATIDE?
Of the 9 reports, 2 (22.2%) required hospitalization, and 2 (22.2%) were considered life-threatening.
Is Product communication issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TIRZEPATIDE. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does TIRZEPATIDE Cause?
Incorrect dose administered (23,301)
Injection site pain (10,989)
Nausea (10,018)
Off label use (7,007)
Extra dose administered (6,774)
Diarrhoea (5,463)
Vomiting (4,635)
Injection site haemorrhage (4,389)
Accidental underdose (3,897)
Injection site erythema (3,844)
What Other Drugs Cause Product communication issue?
EVOLOCUMAB (2,341)
SEMAGLUTIDE (842)
ERENUMAB-AOOE (598)
SOMATROPIN (350)
PEGFILGRASTIM (333)
ETANERCEPT (122)
ALBUTEROL (121)
NIRMATRELVIR\RITONAVIR (70)
DENOSUMAB (68)
LEVODOPA (61)
Which TIRZEPATIDE Alternatives Have Lower Product communication issue Risk?
TIRZEPATIDE vs TISAGENLECLEUCEL
TIRZEPATIDE vs TISLELIZUMAB
TIRZEPATIDE vs TISOTUMAB VEDOTIN
TIRZEPATIDE vs TISOTUMAB VEDOTIN-TFTV
TIRZEPATIDE vs TITANIUM DIOXIDE\ZINC